Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells

Journal of Neuroscience Research

Volumn 90, Issue 5, 2012, Pages 1020-1029

  Álvarez, Gema ^a   Aldudo, Jesús ^a,b   Alonso, María ^c,d   Santana, Soraya ^e   Valdivieso, Fernando ^a,b  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e Drug Discovery Unit   (Spain)

Author keywords

HSV 1; Infection; Neurodegeneration; Phosphorylation

Indexed keywords

ADENOVIRUS VECTOR; SHORT HAIRPIN RNA; TAU PROTEIN; VIRUS DNA;

ALZHEIMER DISEASE; ARTICLE; BRAIN NUCLEUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPLICATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK FACTOR; VIROGENESIS; VIRUS INHIBITION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DNA REPLICATION; DNA, VIRAL; ENZYME INHIBITORS; HERPESVIRUS 1, HUMAN; HUMANS; NEUROBLASTOMA; PHOSPHORYLATION; RNA, SMALL INTERFERING; TAU PROTEINS; TIME FACTORS; VERO CELLS; VIRAL PLAQUE ASSAY;

EID: 84858005272     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23003     Document Type: Article

References (52)

1. Avila J, Lim F, Moreno F, Belmonte C, Cuello AC. 2002. Tau function and dysfunction in neurons: its role in neurodegenerative disorders. Mol Neurobiol 25: 213-231.
2. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM. 1989. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477: 90-99.
3. Brady RM, Zinkowski RP, Binder LI. 1995. Presence of tau in isolated nuclei from human brain. Neurobiol Aging 16: 479-486.
4. Burgos JS, Ramirez C, Sastre I, Bullido MJ, Valdivieso F. 2003. ApoE4 is more efficient than E3 in brain access by herpes simplex virus type 1. Neuroreport 14: 1825-1827.
5. Carrascosa AL, Santaren JF, Vinuela E. 1982. Production and titration of African swine fever virus in porcine alveolar macrophages. J Virol Methods 3: 303-310.
6. Cheng SB, Ferland P, Webster P, Bearer EL. 2011. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 6: e17966.
7. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH. 2003. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40: 471-483.
8. de Bruyn Kops A, Knipe DM. 1988. Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein. Cell 55: 857-868.
9. de Bruyn Kops A, Knipe DM. 1994. Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J Virol 68: 3512-3526.
10. De Chiara G, Marcocci ME, Civitelli L, Argnani R, Piacentini R, Ripoli C, Manservigi R, Grassi C, Garaci E, Palamara AT. 2010. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5: e13989.
11. Delobel P, Flament S, Hamdane M, Mailliot C, Sambo AV, Begard S, Sergeant N, Delacourte A, Vilain JP, Buee L. 2002. Abnormal tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem 83: 412-420.
12. Diaz JJ, Giraud S, Greco A. 2002. Alteration of ribosomal protein maps in herpes simplex virus type 1 infection. J Chromatogr B Anal Technol Biomed Life Sci 771: 237-249.
13. Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA, Gendelman HE. 2003. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23: 9162-9170.
14. Greenberg SG, Davies P, Schein JD, Binder LI. 1992. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267: 564-569.
15. Hamdane M, Sambo AV, Delobel P, Begard S, Violleau A, Delacourte A, Bertrand P, Benavides J, Buee L. 2003. Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J Biol Chem 278: 34026-34034.
16. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. 1994. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369: 488-491.
17. Harborth J, Elbashir SM, Bechert K, Tuschl T, Weber K. 2001. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114: 4557-4565.
18. Hiscox JA. 2002. The nucleolus-a gateway to viral infection? Arch Virol 147: 1077-1089.
19. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. 1997. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241-244.
20. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, Davies P. 1999. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J Neurosci 19: 7486-7494.
21. Johnson K, Liu L, Majdzadeh N, Chavez C, Chin PC, Morrison B, Wang L, Park J, Chugh P, Chen HM, D'Mello SR. 2005. Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs. J Neurochem 93: 538-548.
22. Knipe DM. 1989. The role of viral and cellular nuclear proteins in herpes simplex virus replication. Adv Virus Res 37: 85-123.
23. Lefebvre T, Ferreira S, Dupont-Wallois L, Bussiere T, Dupire MJ, Delacourte A, Michalski JC, Caillet-Boudin ML. 2003. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins-a role in nuclear localization. Biochim Biophys Acta 1619: 167-176.
24. Lerchundi R, Neira R, Valdivia S, Vio K, Concha MI, Zambrano A, Otth C. 2011. Tau cleavage at D421 by caspase-3 is induced in neurons and astrocytes infected with herpes simplex virus type 1. J Alzheimers Dis 23: 513-520.
25. Letenneur L, Peres K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF. 2008. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 3: e3637.
26. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF. 2002. Herpesviruses in brain and Alzheimer's disease. J Pathol 197: 395-402.
27. Lovestone S, Reynolds CH. 1997. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78: 309-324.
28. Mohni KN, Livingston CM, Cortez D, Weller SK. 2010. ATR and ATRIP are recruited to herpes simplex virus type 1 replication compartments even though ATR signaling is disabled. J Virol 84: 12152-12164.
29. Monier K, Armas JC, Etteldorf S, Ghazal P, Sullivan KF. 2000. Annexation of the interchromosomal space during viral infection. Nat Cell Biol 2: 661-665.
30. Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, Matsuoka Y, Ahlijanian M, Lau LF, Duff K. 2003. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38: 555-565.
31. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM. 1991. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci U S A 88: 5837-5841.
32. Papasozomenos SC, Binder LI. 1987. Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil Cytoskeleton 8: 210-226.
33. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. 1999. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615-622.
34. 2+-mediated APP phosphorylation and Abeta accumulation in rat cortical neurons. Neurobiol Aging (in press).
35. Porcellini E, Carbone I, Ianni M, Licastro F. 2010. Alzheimer's disease gene signature says: beware of brain viral infections. Immun Ageing 7: 16.
36. Pyles RB. 2001. The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors. Herpes 8: 64-68.
37. Qin XF, An DS, Chen IS, Baltimore D. 2003. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100: 183-188.
38. Quinlan MP, Chen LB, Knipe DM. 1984. The intranuclear location of a herpes simplex virus DNA-binding protein is determined by the status of viral DNA replication. Cell 36: 857-868.
39. Rice SA, Long MC, Lam V, Spencer CA. 1994. RNA polymerase II is aberrantly phosphorylated and localized to viral replication compartments following herpes simplex virus infection. J Virol 68: 988-1001.
40. Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J. 2011. Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol Aging (in press).
41. Schang LM, Phillips J, Schaffer PA. 1998. Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol 72: 5626-5637.
42. Schang LM, Bantly A, Knockaert M, Shaheen F, Meijer L, Malim MH, Gray NS, Schaffer PA. 2002. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins. J Virol 76: 7874-7882.
43. Smith CA, Bates P, Rivera-Gonzalez R, Gu B, DeLuca NA. 1993. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J Virol 67: 4676-4687.
44. Sultan A, Nesslany F, Violet M, Begard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buee L, Galas MC. 2011. Nuclear tau, a key player in neuronal DNA protection. J Biol Chem 286: 4566-4575.
45. Taylor TJ, Knipe DM. 2004. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J Virol 78: 5856-5866.
46. Thurston VC, Pena P, Pestell R, Binder LI. 1997. Nucleolar localization of the microtubule-associated protein tau in neuroblastomas using sense and anti-sense transfection strategies. Cell Motil Cytoskeleton 38: 100-110.
47. Wilcock D, Lane DP. 1991. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 349: 429-431.
48. Wozniak MA, Itzhaki RF. 2010. Antiviral agents in Alzheimer's disease: hope for the future? Ther Adv Neurol Disord 3: 141-152.
49. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. 2007. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 429: 95-100.
50. Wozniak M, Mee A, Itzhaki R. 2008. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J Pathol 217: 131-138.
51. Wozniak MA, Frost AL, Itzhaki RF. 2009. Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 16: 341-350.
52. Zambrano A, Solis L, Salvadores N, Cortes M, Lerchundi R, Otth C. 2008. Neuronal cytoskeletal dynamic modification and neurodegeneration induced by infection with herpes simplex virus type 1. J Alzheimers Dis 14: 259-269.